Covid-19 vaccine registration step-by-step guide: In an attempt to make Covid-19 vaccine available for all, the central government on Monday announced the third phase of the vaccination drive and this time it is for all those above the age of 18 years. It starts from May 1, 2021.  

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

This means every citizen above 18 years of age, regardless of comorbidities, will now be eligible for the coronavirus vaccine.  A liberalised and accelerated phase three strategy of COVID-19 vaccination drive decision was taken after Prime Minister Narendra Modi met top doctors in the country.  

The vaccines will be free of cost at all government-run Covid-19 centers, whereas private hospitals, can transparently declare a self-set cost for the vaccine.  

Check out the steps to register on the CoWIN app for phase 3 vaccination for people above the age of 18 from May 1.   

COVID-19 Vaccination Phase 3: How to Register 

Visit the official website of CoWIN – cowin.gov.in 

Enter your 10-digit mobile number or Aadhaar number 

You will receive an OTP on the mobile number, enter it in the given space 

Once registered, schedule your preferred date and time 

Get your COVID-19 vaccination done. 

You will get a Reference ID through which you get your vaccination certificate. 

COVID-19 Vaccination Phase 3: Documents Required 

You will need at least one of the following documents at the time of registration, along with a Photo ID 

Aadhaar Card 

PAN Card 

Voter ID 

Driving License 

Health Insurance Smart Card issued under by Ministry of Labour 

Mahatma Gandhi National Rural Employment 

Guarantee Act (MGNREGA) Job Card 

Official identity cards issued to MPs/MLAs/MLCs 

Passport 

Passbooks issued by Bank/Post Office 

Pension Document 

Service Identity Card issued to employees by Central/ State Govt./ Public Limited Companies 

The central government, in its notification, said procurement, eligibility, administration of coronavirus vaccines is being made flexible. The order states, vaccine manufacturers would supply 50 per cent of their monthly Central Drugs Laboratory released doses to the central government and gave relaxation to supply the remaining 50 per cent doses to state governments and in the open market.